TUCSON, Ariz., Jan. 9, 2025 /PRNewswire/ -- SynCardia Systems, LLC ("SynCardia", or the "Company"), a Picard Medical, Inc. company, and the global leader in total artificial heart technology, is pleased to announce that the China National Intellectual Property Administration ("CNIPA")…

The Chandler Arizonan

Chandler

Maricopa County

Arizona

United States

SynCardia Systems Receives Decision to Grant First Patent in China for the Emperor Next-Generation Total Artificial Heart

Media Bias/Fact Check

Queen Creek Tribune

Queen Creek

Gilbert Sun News

January 9, 2025—TriCares SAS, which is based in Paris, France, announced that the first patients have been implanted with the company’s Topaz transcatheter tricuspid heart valve replacement (TTVR) system in an early feasibility study (EFS) in the United States. According to the company, the TRICURE EFS is a prospective, multicenter, single-arm study approved under an FDA investigational device exemption. The study will assess the safety and perf…

Cardiac Interventions Today

TriCares’ Topaz TTVR System’s TRICURE EFS Begins Enrollment - Cardiac Interventions Today

Topaz TRiCares has announced that the first patients have been successfully implanted with Topaz, its transcatheter tricuspid heart valve replacement (TTVR) system, in an early feasibility study (EFS) in the USA. The TRICURE EFS, a prospective, multicentre, single-arm study approved under a US Food and Drug Administration (FDA) IDE, will assess the safety and performance of TRiCares’ Topaz TTVR system in adult patients with severe tricuspid regu…

Cardiovascular News

First patients treated in TRICURE EFS study of Topaz tricuspid heart valve replacement system

SynCardia Systems Receives Decision to Grant First Patent in China for the Emperor Next-Generation Total Artificial Heart

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics